Executive Coffee Chat with Jan Elias Hansen, VP of Evidence for Access at Genentech
Monday, June 13, 2022
9:00 AM - 10:00 AM
Add to Calendar
Pacific Standard Time
Jan Hansen, PhD, is Vice President of the Evidence for Access Unit within Genentech’s US Medical Affairs organization. Her unit is staffed with health economists, outcomes researchers, and health services researchers who are uniquely positioned and skilled to address the value, quality and policy drivers associated with access to health care in the US. These scientists are tasked to consider impacts on value, quality, systems, and policies when developing research strategies and tactics.
Jan is a seasoned executive with more than thirty years of experience in the health care, life sciences and pharmaceutical industries. Jan’s pharmacoeconomics and health outcomes expertise has been acquired and applied throughout her career across a vast set of areas including: patient-based research, health care consulting, sales strategy and execution, strategic planning, organizational design and development, and outcomes research (global and US roles). In addition to Genentech (a member of the Roche Group) she has held positions with increasing leadership responsibility at several well-regarded companies, including PCS-Pharmaceutical Data Services (now CVS-Caremark), NDC Health/Wolters Kluwer Health (now Symphony Health), Glaxo Wellcome (now GlaxoSmithkline), and Allergan (now part of AbbVie).
Her professional accomplishments have been recognized by several professional organizations and resulted in numerous appointments, including: the University of Iowa College of Pharmacy Advisory Council, past Chair and current member of the University of Washington College of Pharmacy’s Corporate Advisory Council, Board member (representing Genentech) of the National Pharmaceutical Council (NPC), past Board member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), past member of the Drug Information Association (DIA) Advisory Council of North America, past NPC Corresponding Officer and Research Committee member (representing Allergan), member of the Academy Health Corporate Council, Center for Evaluation of Value and Risk (CEVR) Life Sciences Advisory Board, PhRMA Foundation Value Assessment Advisory Committee, and past Academy of Managed Care Pharmacy (AMCP) Foundation Board of Trustee, to name a few.
Jan is a licensed pharmacist and holds a Ph.D. in Pharmacy Administration from the University of South Carolina at Columbia. She is also a speaker and guest lecturer on topics related to pharmacoeconomics and outcomes research.
Jan’s ultimate passion is “building”; she takes great pride in building organizations and fostering young, innovative-thinking, yet applied, researchers. As a leader of health economics and health services/outcomes professionals, she is committed to the appropriate training, mentoring and development of the next generation of researchers, and thrives on the application of health economic, outcomes, and health services research. For Jan, there is no greater joy than watching these researchers flourish and making a difference in to health care decision making, and ultimately, to patients’ lives.